Report preliminary results of the Phase 1b trial in patients with Parkinson’s Disease
Delivered after the deadline (133 days after the deadline)
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 10 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- 10 Nov 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Preliminary results are expected by mid-year 2021.”
What we found
Evidence strength A What the grades mean
The company announced the Phase 1b trial results on November 10, 2021, which is after the mid-year 2021 deadline.
-
A Yumanity Therapeutics, Inc. 10-K filed 2022-03-24
“On November 10, 2021, we announced top-line data from our Phase 1b clinical trial of YTX-7739 in patients with mild-to-moderate Parkinson’s disease.” ✓ confirmed on the page
-
A Yumanity Therapeutics, Inc. 8-K filed 2021-08-12
“Topline results for the YTX-7739 Phase 1b trial in Parkinson’s disease patients expected Fall of 2021” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Phase 1b trial preliminary results
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Yumanity Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C445283-023440 · Corrections policy